Back
ESC2025 Premium Access

Clinical impact of kidney function in patients with atrial fibrillation receiving oral anticoagulants

Session: Unmet needs in anticoagulant pharmacotherapy
Topic: Anticoagulants
Speaker: Doctor Y. Matsuoka (Osaka, JP)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Yuki Matsuoka

Osaka University Graduate School of Medicine, Osaka (Japan)
0 follower

7 more presentations in this session

Navigating optimal antithrombotic therapy in atrial fibrillation patients with PCI: insights from the EPIC-CAD trial

Speaker: Doctor S. Wee (Seoul, KR)

Access
Abstract
Slides
Video
Like
Thumbnail

Plasma levels measurement of the four direct oral anticoagulants in patients with atrial fibrillation at the time of acute thromboembolic and bleeding events

Speaker: Doctor R. Mazza (Milan, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Efficacy and safety of direct oral anticoagulants for treatment of left ventricular thrombus

Speaker: Doctor K. Abraham (Stony Brook, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Direct oral anticoagulants versus warfarin for left ventricular thrombus

Speaker: Doctor J. Kassab (Dallas, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Pharmacokinetics and pharmacodynamics of SHR-2004, a novel humanized monoclonal antibody targeting factor XI, in patients with atrial fibrillation

Speaker: Professor J. Jiang (Hangzhou, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Unmet needs in anticoagulant pharmacotherapy

Speakers: Doctor Y. Matsuoka, Doctor S. Wee, Doctor R. Mazza, Doctor K. Abraham, Doctor J. Kassab...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources